Published in Br J Cancer on August 16, 2004
Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only. Obstet Gynecol Int (2011) 0.81
[Current TNM/FIGO classification for cervical and endometrial cancer as well as malignant mixed müllerian tumors. Facts and background]. Pathologe (2011) 0.77
The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer. Int J Gynecol Cancer (2013) 0.76
[Changes in the TNM classification of gynecological tumors]. Pathologe (2010) 0.76
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis. Gynecol Oncol (2016) 0.75
Controversies in the management of endometrial carcinoma: an update. Obstet Gynecol Int (2012) 0.75
Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer (1987) 5.36
FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet (2000) 5.33
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol (1991) 4.62
Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer (2003) 1.03
Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol (1992) 1.02
Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol (1990) 1.02
The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol (2002) 1.02
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am J Obstet Gynecol (1981) 0.99
Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett (2001) 0.99
Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy. Br J Cancer (2003) 0.95
Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology. Int J Radiat Oncol Biol Phys (1988) 0.93
The importance of peritoneal cytology in endometrial carcinoma. Obstet Gynecol (1988) 0.89
Prognostic value of peritoneal fluid cytology in patients with endometrial cancer stage I. Eur J Obstet Gynecol Reprod Biol (1984) 0.80
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat (2012) 3.99
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Radioactive seed localization for non-palpable breast cancer. Br J Surg (2013) 2.07
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86
Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. The Dose-Finding Study Group. N Engl J Med (2001) 1.84
Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe. Eur J Cancer (2009) 1.66
Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer (2007) 1.57
Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. A clinical pilot study. Circulation (1997) 1.55
Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers. Int J Epidemiol (2007) 1.54
Combined chemotherapy and radiotherapy, followed or not by surgery, in squamous cell carcinoma of the esophagus. Ann Oncol (1995) 1.48
Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer (2000) 1.47
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon. Int J Gynecol Cancer (2007) 1.40
The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res (2007) 1.37
Disability, mortality, and incidence of cancer among Geneva painters and electricians: a historical prospective study. Br J Ind Med (1989) 1.33
Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res (1998) 1.29
Mechanisms of neointima formation and remodeling in the porcine coronary artery. Circulation (2001) 1.28
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin. J Pharmacol Exp Ther (1998) 1.21
Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison. Int J Radiat Oncol Biol Phys (1993) 1.19
Risk factors for male breast cancer: a Franco-Swiss case-control study. Int J Cancer (1990) 1.18
Maternal mortality in Maroua Provincial Hospital, Cameroon (2003-2005). West Indian Med J (2007) 1.11
Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat (2012) 1.10
An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians. Pharmacogenetics (1998) 1.09
Permanent work incapacity, mortality and survival without work incapacity among occupations and social classes: a cohort study of ageing men in Geneva. Int J Epidemiol (1998) 1.06
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. J Thorac Cardiovasc Surg (2000) 1.05
A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin. J Pharmacol Exp Ther (1999) 1.05
Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol (2003) 1.04
High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res (2000) 1.03
Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin. J Pharmacol Exp Ther (1998) 1.03
Unusual mortality pattern among short term workers in the perfumery industry in Geneva. Br J Ind Med (1987) 1.00
Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer (1999) 0.95
Impact of peritoneal cytology on survival of endometrial cancer patients treated with surgery and radiotherapy. Br J Cancer (2003) 0.95
Increased risk for lung cancer and for cancer of the gastrointestinal tract among Geneva professional drivers. Br J Ind Med (1992) 0.94
Tumour cell displacement after 14G breast biopsy. Eur J Surg Oncol (2004) 0.94
Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol (2005) 0.94
Impact of breast surgery on survival in women presenting with metastatic breast cancer. Br J Surg (2011) 0.93
Surveys on mammography frequency in Geneva. J Med Screen (2000) 0.92
Multiple primary cancers and estimation of the incidence rates and trends. Eur J Cancer (1996) 0.91
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls. Int J Cancer (2004) 0.89
Tumor incidence in related hematopoietic stem cell donors. Bone Marrow Transplant (2010) 0.89
Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors. Ann Oncol (2009) 0.88
Mortality and incidence of cancer among a cohort of self employed butchers from Geneva and their wives. Br J Ind Med (1993) 0.88
Poorer survival of elderly patients with ovarian cancer: a population-based study. Surg Oncol (2004) 0.88
Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol (2004) 0.87
Treatment of breast cancer in the elderly: a prospective, population-based Swiss study. J Geriatr Oncol (2012) 0.87
Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. Pharmacogenetics (1998) 0.87
Breast cancer incidence trends in European women aged 20-39 years at diagnosis. Breast Cancer Res Treat (2012) 0.86
Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations. Breast Cancer Res Treat (2007) 0.86
Photodynamic diagnosis of ovarian cancer using hexaminolaevulinate: a preclinical study. Br J Cancer (2003) 0.86
Management of women with ductal carcinoma in situ of the breast: a population-based study. Ann Oncol (2002) 0.86
Geographical disparities in self-reported use of mammography and breast self-examination according to the Swiss Health Survey. Ann Oncol (2001) 0.86
[Cervical cancer screening: current status and perspectives]. Rev Med Suisse (2006) 0.85
Intra-arterial beta irradiation prevents neointimal hyperplasia in a hypercholesterolemic rabbit restenosis model. Circulation (1995) 0.85
Intraoperative ultrasound guidance for excision of non-palpable invasive breast cancer: a hospital-based series and an overview of the literature. Breast Cancer Res Treat (2012) 0.85
Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiol Biomarkers Prev (1998) 0.85
Increased risk of acute myeloid leukaemia after treatment for breast cancer. Breast (2006) 0.84
Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 0.84
Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas. Eur J Gynaecol Oncol (2008) 0.84
Intraarterial beta irradiation induces smooth muscle cell apoptosis and reduces medial cellularity in a hypercholesterolemic rabbit restenosis model. Int J Radiat Oncol Biol Phys (2000) 0.84
Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregates. Cardiovasc Intervent Radiol (2010) 0.83
Feasibility and tolerance of pulsed dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys (1999) 0.83
High- and intermediate-risk human papillomavirus infection in sexually active adolescent females. J Pediatr Adolesc Gynecol (2001) 0.83
Impact of a positive family history on diagnosis, management, and survival of breast cancer: different effects across socio-economic groups. Cancer Causes Control (2009) 0.83
Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based study. Clin Transl Oncol (2009) 0.83
Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality. Eur Radiol (2014) 0.82
[Historical cohort study of delivery in women of forty years of age and older]. Rev Med Liege (2007) 0.82
Assessment of a fully automated, high-throughput mammographic density measurement tool for use with processed digital mammograms. Cancer Causes Control (2014) 0.81
Gender ratio of offspring and exposure to shortwave radiation among female physiotherapists. Scand J Work Environ Health (1994) 0.81
Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers. Pharmacogenetics (1999) 0.81
Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III. Eur J Cancer (2012) 0.81
Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality. Ann Oncol (2009) 0.81
Life course social mobility and risk of upper aerodigestive tract cancer in men. Eur J Epidemiol (2010) 0.80
In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model. J Am Assoc Gynecol Laparosc (1998) 0.80
Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study. Ann Oncol (2011) 0.80
[Outcome of delivery at extreme ages of reproductive life]. Rev Med Liege (2004) 0.80
Endometrial cytohistology by the pistol-aspiration technique: clinical applicability. Obstet Gynecol (1987) 0.80
Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer (2006) 0.80
Cost comparison between stereotactic large-core-needle biopsy versus surgical excision biopsy in The Netherlands. Eur J Cancer (2001) 0.79
Adjuvant chemotherapy for colon carcinoma with positive lymph nodes: use and benefit in routine health care practice. Br J Cancer (2001) 0.79
CYP2D6 gene polymorphism in caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. Eur J Cancer (2000) 0.78
Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. Pharmacogenetics (1997) 0.78
Prescribing, recording, and reporting in endovascular brachytherapy. Quality assurance, equipment, personnel and education. Radiother Oncol (2001) 0.78